Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging

Experimental Gerontology

Volumn 55, Issue , 2014, Pages 134-142

  Pascual, Ana C ^a   Gaveglio, Virginia L ^a   Giusto, Norma M ^a   Pasquaré, Susana J ^a  

^a Instituto de Investigaciones Bioquimicas Bahia Blanca   (Argentina)

Author keywords

2 Arachidonoylglycerol; Aging; Cannabinoid receptors; Diacylglycerol lipase; Lysophosphatidate phosphohydrolase; Monoacylglycerol lipase

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; LIPOPROTEIN LIPASE; LYSOPHOSPHATIDATE PHOSPHOHYDROLASE; PHOSPHATASE; RIMONABANT; UNCLASSIFIED DRUG; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; CNR2 PROTEIN, RAT; ENDOCANNABINOID; PHOSPHATIDATE PHOSPHATASE;

ADULT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FATTY ACID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; RAT; SYNAPTOSOME; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

AGING; ANIMALS; ARACHIDONIC ACIDS; CELL MEMBRANE; CEREBRAL CORTEX; ENDOCANNABINOIDS; GLYCERIDES; LIPOPROTEIN LIPASE; MONOACYLGLYCEROL LIPASES; PHOSPHATIDATE PHOSPHATASE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; SYNAPTOSOMES;

EID: 84899839524     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.04.008     Document Type: Article

References (49)

1. Ahn K., McKinney M.K., Cravatt B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 2008, 108:1687-1707.
2. Bahr B.A., Karanian D.A., Makanji S.S., Makriyannis A. Targeting the endocannabinoid system in treating brain disorders. Expert Opin. Investig. Drugs 2006, 15:351-365.
3. Basavarajappa B.S. Critical enzymes involved in endocannabinoid metabolism. Protein Pept. Lett. 2007, 14:237-246.
4. Berrendero F., Romero J., Garcia-Gil L., Suarez I., De la Cruz P., Ramos J.A., Fernandez-Ruiz J.J. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim. Biophys. Acta 1998, 1407:205-214.
5. Bilkei-Gorzo A. The endocannabinoid system in normal and pathological brain ageing. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367:3326-3341.
6. Bisogno T., Melck D., De Petrocellis L., Di Marzo V. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J. Neurochem. 1999, 72:2113-2119.
7. Blankman J.L., Simon G.M., Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 2007, 14:1347-1356.
8. Breivogel C.S., Walker J.M., Huang S.M., Roy M.B., Childers S.R. Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. Neuropharmacology 2004, 47:81-91.
9. Callen L., Moreno E., Barroso-Chinea P., Moreno-Delgado D., Cortes A., Mallol J., Casado V., Lanciego J.L., Franco R., Lluis C., Canela E.I., McCormick P.J. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. J. Biol. Chem. 2012, 287:20851-20865.
10. Carrier E.J., Kearn C.S., Barkmeier A.J., Breese N.M., Yang W., Nithipatikom K., Pfister S.L., Campbell W.B., Hillard C.J. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol. 2004, 65:999-1007.
11. Chang J.W., Niphakis M.J., Lum K.M., Cognetta A.B., Wang C., Matthews M.L., Niessen S., Buczynski M.W., Parsons L.H., Cravatt B.F. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates. Chem. Biol. 2012, 19:579-588.
12. Cotman C.W. Isolation of synaptosomal and synaptic plasma membrane fractions. Methods Enzymol. 1974, 31:445-452.
13. De Petrocellis L., Ligresti A., Moriello A.S., Allara M., Bisogno T., Petrosino S., Stott C.G., Di Marzo V. Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Pharmacol. 2011, 163:1479-1494.
14. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
15. Di Marzo V., Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol. 2007, 18:129-140.
16. Fleming I.N., Yeaman S.J. Subcellular distribution of N-ethylmaleimide-sensitive and -insensitive phosphatidic acid phosphohydrolase in rat brain. Biochim. Biophys. Acta 1995, 1254:161-168.
17. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
18. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
19. 14C]glycerol in the bovine retina: the effects of incubation time, oxygen and glucose. Exp. Eye Res. 1979, 29:155-168.
20. Golech S.A., McCarron R.M., Chen Y., Bembry J., Lenz F., Mechoulam R., Shohami E., Spatz M. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res. Mol. Brain Res. 2004, 132:87-92.
21. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006, 1071:10-23.
22. Govaerts S.J., Hermans E., Lambert D.M. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors. Eur. J. Pharm. Sci. 2004, 23:233-243.
23. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 1991, 11:563-583.
24. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 2002, 68-69:619-631.
25. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 2005, 5:400-411.
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
27. Ledesma M.D., Martin M.G., Dotti C.G. Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog. Lipid Res. 2012, 51:23-35.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
29. Ludanyi A., Eross L., Czirjak S., Vajda J., Halasz P., Watanabe M., Palkovits M., Magloczky Z., Freund T.F., Katona I. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J. Neurosci. 2008, 28:2976-2990.
30. Mackie K. Signaling via CNS cannabinoid receptors. Mol. Cell. Endocrinol. 2008, 286:S60-S65.
31. Maldonado R., Valverde O., Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006, 29:225-232.
32. Mulder J., Zilberter M., Pasquare S.J., Alpar A., Schulte G., Ferreira S.G., Kofalvi A., Martin-Moreno A.M., Keimpema E., Tanila H., Watanabe M., Mackie K., Hortobagyi T., de Ceballos M.L., Harkany T. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain 2011, 134:1041-1060.
33. Nakane S., Oka S., Arai S., Waku K., Ishima Y., Tokumura A., Sugiura T. 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. Arch. Biochem. Biophys. 2002, 402:51-58.
34. Onaivi E.S. Commentary: functional neuronal CB2 cannabinoid receptors in the CNS. Curr. Neuropharmacol. 2011, 9:205-208.
35. Pascual A.C., Gaveglio V.L., Giusto N.M., Pasquare S.J. Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism. Biofactors 2013, 39:209-220.
36. Pasquare de Garcia S.J., Giusto N.M. Phosphatidate phosphatase activity in isolated rod outer segment from bovine retina. Biochim. Biophys. Acta 1986, 875:195-202.
37. Pertwee R.G. Pharmacological actions of cannabinoids. Handb. Exp. Pharmacol. 2005, 1-51.
38. Prescott S.M., Majerus P.W. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J. Biol. Chem. 1983, 258:764-769.
39. Ramirez B.G., Blazquez C., Gomez del Pulgar T., Guzman M., de Ceballos M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 2005, 25:1904-1913.
40. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., Soubrie P., Breliere J.C., Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 1995, 56:1941-1947.
41. Rinaldi-Carmona M., Barth F., Millan J., Derocq J.M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Breliere J.C., Le Fur G.L. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 1998, 284:644-650.
42. Sanchez A.J., Garcia-Merino A. Neuroprotective agents: cannabinoids. Clin. Immunol. 2012, 142:57-67.
43. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
44. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215:89-97.
45. Sugiura T., Kobayashi Y., Oka S., Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 2002, 66:173-192.
46. Svizenska I., Dubovy P., Sulcova A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review. Pharmacol. Biochem. Behav. 2008, 90:501-511.
47. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
48. Wang J., Ueda N. Role of the endocannabinoid system in metabolic control. Curr. Opin. Nephrol. Hypertens. 2008, 17:1-10.
49. Zanettini C., Panlilio L.V., Alicki M., Goldberg S.R., Haller J., Yasar S. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front. Behav. Neurosci. 2011, 5:57.